Grifols S.A. Logo

Grifols S.A.

Develops and produces plasma-derived medicines and biopharmaceutical solutions.

GRF | MC

Overview

Corporate Details

ISIN(s):
ES0171996087 (+4 more)
LEI:
959800HSSNXWRKBK4N60
Country:
Spain
Address:
Avenida de la Generalitat 152-158, 08174 Sant Cugat del Vallès

Description

Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-02-22 00:00
Corporate Governance Report - Grifols S.A.
Spanish 164.2 KB
2021-01-19 11:04
Grifols inicia un ensayo clínico con un nuevo medicamento que proporcionaría in…
Spanish 16.5 KB
2020-12-16 16:09
El Consejo de Administración de Grifols, S.A. ha acordado, en su reunión del 11…
Spanish 18.6 KB
2020-12-15 17:39
Como continuación a la “Otra Información Relevante” comunicada en fecha 7 de se…
Spanish 18.2 KB
2020-11-24 14:53
Grifols ha firmado un acuerdo vinculante (Master Joint Venture Agreement) con l…
Spanish 15.2 KB
2020-11-09 17:48
Como continuación al hecho relevante de fecha 26 de enero de 2018, Grifols info…
Spanish 35.2 KB
2020-10-21 15:06
Reunión de inversores y analistas 2020
English 10.4 MB
2020-10-09 13:42
Junta General Ordinaria 2020
Spanish 5.3 MB
2020-10-01 17:37
Grifols informa sobre el cierre en el día de hoy de la operación con el grupo s…
Spanish 8.1 KB
2020-09-07 08:26
Grifols informa que ha llegado a un acuerdo con los accionistas de Alkahest Inc…
Spanish 35.8 KB
2020-09-07 00:00
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2020-09-04 08:40
Convocatoria de la Junta General Ordinaria 2020 de Grifols, S.A.
Spanish 40.4 KB
2020-07-31 00:00
Motivo de la notificación: Persona con Responsabilidad de Dirección
Spanish 91.4 KB
2020-07-30 09:22
1H2020 consolidated interim financial statements
English 3.2 KB
2020-07-30 09:16
1H2020 Earnings results
English 3.1 KB

Automate Your Workflow. Get a real-time feed of all Grifols S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Grifols S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Grifols S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.